Solabia Group

In 1972, Gérard Josset founded Solabia, a company that would grow from its origins in enzymatic hydrolysis to become a key global player in specialty ingredients. Based in France, the company initially focused on developing and producing ingredients for the pharmaceutical, nutrition, and cosmetics industries. This foundation in biotechnology set the stage for decades of expansion. The company’s playbook centered on a dual strategy: internal innovation and aggressive external growth through acquisitions. This approach allowed Solabia to steadily build a comprehensive portfolio. Over the years, it acquired companies with complementary expertise, such as BioEurope and Algatech, expanding its technological capabilities and market reach. This strategy of acquiring specialized firms like AppleChem and PolymerExpert allowed Solabia to enhance its offerings in high-demand areas like cosmetics and healthcare. A significant chapter in Solabia's story began in 2018 when private equity firm TA Associates invested in the company, aiming to accelerate its transformation into a global life sciences platform. This partnership fueled further growth, both organically and through more acquisitions. In May 2025, another major event occurred when the private equity firm Astorg acquired a majority stake in the group, with TA Associates reinvesting to remain a partner. This new backing aims to push Solabia’s international expansion, particularly in the U.S. and Asia, and to continue its track record of innovation in the ingredients market.